Cargando…
Development and validation of a nomogram to predict the recurrence of hepatocellular carcinoma patients with dynamic changes in AFP undergoing locoregional treatments
BACKGROUND: Serum alpha-fetoprotein (AFP) is an important clinical indicator for screening, diagnosis, and prognosis of primary hepatocellular carcinoma (HCC). Our team’s previous study showed that patients with negative AFP at baseline and positive AFP at relapse had a worse prognosis (N-P). Theref...
Autores principales: | Sun, Yu, Xiong, Yiqi, Wang, Qi, Qiao, Wenying, Zhang, Honghai, Zhang, Yonghong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494718/ https://www.ncbi.nlm.nih.gov/pubmed/37700838 http://dx.doi.org/10.3389/fonc.2023.1206345 |
Ejemplares similares
-
The Dynamic Changes of AFP From Baseline to Recurrence as an Excellent Prognostic Factor of Hepatocellular Carcinoma After Locoregional Therapy: A 5-Year Prospective Cohort Study
por: Wang, Qi, et al.
Publicado: (2021) -
Establishment and validation of nomogram model for the diagnosis of AFP-negative hepatocellular carcinoma
por: Liu, Long, et al.
Publicado: (2023) -
Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma
por: Wang, Qi, et al.
Publicado: (2022) -
Development and Validation of a Prognostic Nomogram in AFP-negative hepatocellular carcinoma
por: Wang, Xueping, et al.
Publicado: (2019) -
Simple Clinical Metrics Enhance AFP to Effectively Identify Cirrhotic Patients With Complicating Hepatocellular Carcinoma at Various AFP Levels
por: Zhang, Xi, et al.
Publicado: (2020)